UV-induced generation of rare tautomers of allopurinol and 9-methylhypoxanthine - A matrix isolation FTIR study

Biophysical Chemistry

Volumn 122, Issue 2, 2006, Pages 123-135

  Gerega, A ^a   Lapinski, L ^a   Reva, I ^a,b   Rostkowska, H ^a   Nowak, M J ^a  

^a INSTITUTE OF PHYSICS   (Poland)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

4(3H) pyrimidinone; 9 methylhypoxanthine; Allopurinol; DFT calculations; FTIR spectroscopy; Hypoxanthine; Inosine; Matrix isolation; Photochemistry; Tautomerism

Indexed keywords

4 PYRIMIDINONE DERIVATIVE; 9 METHYLHYPOXANTHINE; ALLOPURINOL; ARGON; HYPOXANTHINE; HYPOXANTHINE DERIVATIVE; INOSINE; KETENE DERIVATIVE; MONOMER; UNCLASSIFIED DRUG;

ARTICLE; DENSITY FUNCTIONAL THEORY; INFRARED RADIATION; INFRARED SPECTROSCOPY; LOW TEMPERATURE; PHOTOCHEMISTRY; PHOTOREACTIVITY; PRIORITY JOURNAL; PROTON TRANSPORT; RADIATION EXPOSURE; ULTRAVIOLET RADIATION;

ALLOPURINOL; COMPUTER SIMULATION; HYPOXANTHINES; ISOMERISM; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PYRIMIDINONES; QUANTUM THEORY; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; ULTRAVIOLET RAYS;

EID: 33745713046     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2006.03.002     Document Type: Article

References (45)

1. Stryer L. Biochemistry. fourth edition (1995), W.H. Freeman and Company, New York
2. Mitra S.K., and Ninio J. Recognition between codon and anticodon, The limits of our knowledge. FEBS Symp. 51 (1978) 437-444
3. Smith J.L. Enzymes of nucleotide synthesis. Curr. Opin. Struct. Biol. 5 (1995) 752-757
4. Wakai A., Winter D.C., Street J.T., O'Sullivan R.G., Wang J.H., and Redmond H.P. Inosine attenuates tourniquet-induced skeletal muscle reperfusion injury. J. Surg. Res. 99 (2001) 311-315
5. Wortmann R.L. Recent advances in the management of gout and hyperuricemia. Curr. Opin. Rheumatol. 17 (2005) 319-324
6. Wortmann R.L. Gout and hyperuricemia. Curr. Opin. Rheumatol. 14 (2002) 281-286
7. Pea E. Pharmacology of drugs for hyperuricemia - mechanisms, kinetics and interactions. Contrib. Nephrol. 147 (2005) 35-46
8. Bellinghieri G., Santoro D., and Savica V. Pharmacological treatment of acute and chronic hyperuricemia in kidney diseased patients. Contrib. Nephrol. 147 (2005) 149-160
9. Emmerson B.T. Drug therapy - the management of gout. New Engl. J. Med. 334 (1996) 445-451
10. Schlesinger N. Management of acute and chronic gouty arthritis - present state-of-the-art. Drugs 64 (2004) 2399-2416
11. Cairo M.S., and Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br. J. Haematol. 127 (2004) 3-11
12. Holdsworth M.T., and Nguyen P. Role of i.v. allopurinol and rasburicase in tumor lysis syndrome. Am. J. Health-Syst. Pharm. 60 (2003) 2213-2222
13. Adachi H., Motomatsu K., and Yara I. Effect of allopurinol (zyloric) on patients undergoing open heart surgery. Jpn. Circ. J. 43 (1979) 395-401
14. Mellin F., Monteil C., Isabelle M., Di Melgio B., Henry J.P., Thuillez C., and Mulder P. Long-term allopurinol treatment initiated in well established chronic heart failure improves cardiac function and structure. Free Radic. Biol. Med. 37 Suppl. 1 (2004) S39
15. Guan W., Osanai T., Kamada T., Hanada H., Ishizaka H., Onodera H., Iwasa A., Fujita N., Kudo S., Ohkubo T., and Okumura K. Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J. Cardiovasc. Pharmacol. 41 (2003) 699-705
16. Weimert N.A., Tanke W.F., and Sims J.J. Allopurinol as a cardioprotectant during coronary artery bypass graft surgery. Ann. Pharmacother. 37 (2003) 1708-1711
17. Movahed A., Nair K., Ashavaid T.F., and Kumar P. Free radical generation and role of allopurinol as a cardioprotective agent during coronary artery bypass grafting surgery. Can. J. Cardiol. 12 (1996) 138-144
18. Machado-Vieira R., Kapczinski F., Souza D.O., Lara D.R., and Soares J.C. A double-blind controlled study of adjunctive allopurinol or dipyridamole to lithium in the treatment of bipolar mania: preliminary results. Bipolar Disord. 7 Suppl. 2 (2005) 73
19. Akhondzadeh S., Safarcherati A., and Amini H. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial. Prog. Neuro-Psychopharmacol. 29 (2005) 253-259
20. Prusiner P., and Sundaralingam M. Stereochemistry of nucleic acids and their constituents, XXIX, Crystal and molecular structure of allopurinol, a potent inhibitor of xanthine oxidase. Acta Crystallogr., B 28 (1972) 2148-2152
21. Shukla M.K., and Mishra P.C. Electronic spectra and structure of allopurinol: a xanthine oxidase inhibitor. Spectrochim. Acta, Part A 52 (1996) 1547-1557
22. Torreggiani A., Tamba M., Trinchero A., and Fini G. A spectroscopic and pulse radiolysis study of allopurinol and its copper complex. J. Mol. Struct. 651-653 (2003) 91-99
23. Chenon M.T., Pugmire R.J., Grant D.M., Panzica R.P., and Townsend L.B. Carbon-13 NMR spectra of C-Nucleosides, II, A study on the tautomerism of formycin and formycin B by the use of CMR spectroscopy. J. Heterocycl. Chem. 10 (1973) 431-433
24. Fish R.H., and Jaouen G. Bioorganometallic chemistry: structural diversity of organometallic complexes with bioligands and molecular recognition studies of several supramolecular hosts with biomolecules, alkali-metal ions, and organometallic pharmaceuticals. Organometallics 22 (2003) 2166-2177
25. Freisinger E., Rother I.B., Lüth M.S., and Lippert B. Canonical and unconventional pairing schemes between bis(nucleobase) complexes of trans-a2PtII: artificial nucleobase quartets and COH···N bonds. PNAS 100 (2003) 3748-3753
26. Lin J., Yu C., Peng S., Akiyama I., Li K., Li Kao Lee, and LeBreton P.R. Ultraviolet photoelectron studies of the ground-state electronic structure and gas-phase tautomerism of hypoxanthine and guanine. J. Phys. Chem. 84 (1980) 1006-1012
27. Munns A.R.I., and Tollin P. The crystal and molecular structure of inosine. Acta Crystallogr., B 26 (1970) 1101-1113
28. Becke A. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys. Rev., A 38 (1988) 3098-3100
29. Lee C.T., Yang W.T., and Parr R.G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev., B 37 (1988) 785-789
30. Schachtschneider J.H. Technical Report (1969), Shell Development Co., Emeryville, CA
31. Pulay P., Fogarasi G., Pang F., and Boggs J.E. Systematic ab initio gradient calculation of molecular geometries, force constants, and dipole moment derivatives. J. Am. Chem. Soc. 101 (1979) 2550-2560
32. Keresztury G., and Jalsovszky G. An alternative calculation of the vibrational potential energy distribution. J. Mol. Struct. 10 (1971) 304-305
33. Møller C., and Plesset M.S. Note on an approximation treatment for many-electron systems. Phys. Rev. 46 (1934) 618-622
34. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Zakrzewski V.G., Montgomery Jr. J.A., Stratmann R.E., Burant J.C., Dapprich S., Millam J.M., Daniels A.D., Kudin K.N., Strain M.C., Farkas O., Tomasi J., Barone V., Cossi M., Cammi R., Mennucci B., Pomelli C., Adamo C., Clifford S., Ochterski J., Petersson G.A., Ayala P.Y., Cui Q., Morokuma K., Malick D.K., Rabuck A.D., Raghavachari K., Foresman J.B., Cioslowski J., Ortiz J.V., Baboul A.G., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Gomperts R., Martin R.L., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Challacombe M., Gill P.M.W., Johnson B., Chen W., Wong M.W., Andres J.L., Gonzalez C., Head-Gordon M., Replogle E.S., and Pople J.A. Gaussian 98, Revision A.7 (1998), Gaussian, Inc., Pittsburgh, PA
35. Hernandez B., Luque F.J., and Orozco M. Tautomerism of xanthine oxidase substrates hypoxanthine and allopurinol. J. Org. Chem. 61 (1996) 5964-5971
36. Costas M.E., and Acevedo-Chavez R. Density functional study of neutral allopurinol tautomeric forms. J. Comput. Chem. 20 (1999) 200-206
37. ** calculated infrared spectra of 4(3H)-pyrimidinone and 4-hydroxypyrimidine with matrix isolation spectra. Vibr. Spectrosc. 8 (1995) 331-342
38. Nowak M.J., Lapinski L., and Fulara J. IR spectra and phototautomerism of matrix isolated 4-oxopyrimidine. J. Mol. Struct. 175 (1988) 91-96
39. Lapinski L., Fulara J., and Nowak M.J. Infrared matrix isolation and ab initio studies of 4-oxopyrimidine; separation of the spectra of tautomers based on the phototautomeric effect. Spectrochim. Acta A 46 (1990) 61-71
40. Lapinski L., Nowak M.J., Les A., and Adamowicz L. Ab initio calculations of IR spectra in identification of products of matrix isolation photochemistry: dewar form of 4(3H)-pyrimidinone. J. Am. Chem. Soc. 116 (1994) 1461-1467
41. Breda S., Reva I., Lapinski L., and Fausto R. Matrix isolation FTIR and theoretical study of alpha-pyrone photochemistry. Phys. Chem. Chem. Phys. 6 (2004) 929-937
42. Ramaekers R., Maes G., Adamowicz L., and Dkhissi A. Matrix-isolation FT-IR study and theoretical calculations of the vibrational, tautomeric and H-bonding properties of hypoxanthine. J. Mol. Struct. 560 (2001) 205-221
43. 2O. J. Phys. Chem., A 106 (2002) 4502-4512
44. Costas M.E., and Acevedo-Chavez R. Density functional study of the neutral hypoxanthine tautomeric forms. J. Phys. Chem., A 101 (1997) 8309-8318
45. Shukla M.K., and Leszczynski J. A DFT investigation on the effects of hydration on the tautomeric equilibria of hypoxanthine. J. Mol. Struct., Theochem 529 (2000) 99-112